Free Trial

MaxCyte (MXCT) Competitors

MaxCyte logo
GBX 1.65 -0.06 (-3.51%)
As of 10/6/2025

MXCT vs. MAST, ADV, ABM, RGP, LEAF, NEO, TCY, ACM, PRG, and AMFW

Should you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include MAST Energy Developments (MAST), Advance Energy (ADV), African Battery Metals (ABM), Ross Group (RGP), Leaf Clean Energy (LEAF), Neo Energy Metals (NEO), 1619348 (TCY.L) (TCY), 435793 (ACM.L) (ACM), 49379 (PRG.L) (PRG), and AMFW.L (AMFW). These companies are all part of the "business services" industry.

MaxCyte vs. Its Competitors

MaxCyte (LON:MXCT) and MAST Energy Developments (LON:MAST) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

MAST Energy Developments has lower revenue, but higher earnings than MaxCyte. MAST Energy Developments is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte£35.75M0.05-£45.08M-£0.40-4.13
MAST Energy Developments£1.26M6.67-£3.26M-£0.14-251.47

In the previous week, MaxCyte had 3 more articles in the media than MAST Energy Developments. MarketBeat recorded 3 mentions for MaxCyte and 0 mentions for MAST Energy Developments. MaxCyte's average media sentiment score of 1.58 beat MAST Energy Developments' score of 0.00 indicating that MaxCyte is being referred to more favorably in the media.

Company Overall Sentiment
MaxCyte Very Positive
MAST Energy Developments Neutral

24.0% of MaxCyte shares are owned by institutional investors. Comparatively, 0.2% of MAST Energy Developments shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by company insiders. Comparatively, 24.7% of MAST Energy Developments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

MaxCyte has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, MAST Energy Developments has a beta of -0.58, indicating that its stock price is 158% less volatile than the S&P 500.

MAST Energy Developments has a net margin of 0.00% compared to MaxCyte's net margin of -78.37%. MaxCyte's return on equity of -16.01% beat MAST Energy Developments' return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-78.37% -16.01% -11.07%
MAST Energy Developments N/A -695.03%-14.56%

Summary

MaxCyte beats MAST Energy Developments on 8 of the 13 factors compared between the two stocks.

Get MaxCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MXCT vs. The Competition

MetricMaxCyteMedical Devices IndustryMedical SectorLON Exchange
Market Cap£1.75M£2.60B£6.15B£2.61B
Dividend YieldN/A2.44%5.66%5.28%
P/E Ratio-4.13197.8385.994,407.33
Price / Sales0.05135.20628.97100,282.00
Price / Cash1.9715.9938.3227.90
Price / Book0.013.9312.958.77
Net Income-£45.08M£132.05M£3.30B£5.89B
7 Day Performance3.12%-0.65%3.69%0.40%
1 Month Performance17.02%3.28%10.68%6.03%
1 Year Performance-99.43%17.07%83.35%150.70%

MaxCyte Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MXCT
MaxCyte
N/AGBX 1.65
-3.5%
N/A-99.4%£1.75M£35.75M-4.1380High Trading Volume
MAST
MAST Energy Developments
N/AGBX 41
+2.5%
N/A+30,599.4%£6.05M£1.26M-301.4729,900High Trading Volume
ADV
Advance Energy
N/AN/AN/AN/A£2.67M£16K-0.2975,000Gap Up
High Trading Volume
ABM
African Battery Metals
N/AN/AN/AN/A£2.00MN/A-0.12127,000Gap Down
RGP
Ross Group
N/AN/AN/AN/A£1.63M£43K-90.004,260Gap Down
LEAF
Leaf Clean Energy
N/AN/AN/AN/A£458K-£2M2.80346News Coverage
Positive News
Gap Down
High Trading Volume
NEO
Neo Energy Metals
N/AGBX 0.01
flat
N/AN/A£150KN/A1.792,100
TCY
1619348 (TCY.L)
N/AN/AN/AN/A£0.00N/A0.004,800
ACM
435793 (ACM.L)
N/AN/AN/AN/A£0.00N/A0.0050,000
PRG
49379 (PRG.L)
N/AN/AN/AN/A£0.00N/A0.001,690High Trading Volume
AMFW
AMFW.L
N/AN/AN/AN/A£0.00N/A0.0034,013

Related Companies and Tools


This page (LON:MXCT) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners